Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

    Stock Recap
    #PipelineProspector

    Menu

    Sodium Dihydrogen Phosphate Dihydrate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 13Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    27/02/2026 Dr. Paul Lohmann GmbH & Co. KGaA
    Germany
    		 DR. PAUL LOHMANN GMBH & CO. KGAA Emmerthal DE CEP 2019-228 - Rev 02 Sodium dihydrogen phosphate dihydrate 2025-12-22 Valid Chemical 194
    27/02/2026 Quality Chemicals
    Spain
    		 QUALITY CHEMICALS S.L. Esparreguera ES CEP 2017-177 - Rev 02 Sodium dihydrogen phosphate dihydrate 2023-09-26 Valid Chemical 194
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.